Thermo Fisher Scientific Hits Day High with 3.5% Surge in Stock Price
Thermo Fisher Scientific, Inc. saw a significant rise in stock performance on October 3, 2025, reaching an intraday high. The company has demonstrated strong momentum over the past week and month, although it has faced challenges over the past year. Its financial health remains solid, supported by robust growth and high institutional ownership.
Thermo Fisher Scientific, Inc. has experienced a notable uptick in its stock performance, gaining 3.5% on October 3, 2025. The stock reached an intraday high of USD 545.44, reflecting a strong day of trading for the large-cap company in the Pharmaceuticals & Biotechnology sector. Over the past week, Thermo Fisher has shown impressive momentum, with a 17.03% increase, significantly outperforming the S&P 500, which saw a modest rise of 1.09%. In the last month, the stock has risen by 12.13%, again surpassing the S&P 500's 4.15% gain. However, it is important to note that the stock has faced challenges over the past year, with a decline of 9.59%, contrasting sharply with the S&P 500's 17.82% increase.
Thermo Fisher's financial health remains robust, evidenced by a strong EBIT to Interest ratio of 11.00 and a healthy long-term growth trajectory, with net sales growing at an annual rate of 10.48%. The company maintains high institutional ownership at 93.65%, indicating confidence from larger investors in its fundamentals.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
